From BioHealth Investor
The following articles were the most popular at BioHealth Investor for the week of February 17 – February 23.
1. Novadel Drops After Zensana Launch Delayed by Hana Biosciences
2. Acorda therapeutics: Pipeline Does Not Support Valuation
3. Merck Pressured to Halt Gardasil Vaccine Lobbying
4. State Healthcare & Pharmaceutical Legislature Roundup
5. Tiny Biosante Could Skyrocket with Estrogen Replacement Gel
http://www.biohealthinvestor.com/
Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
